دورية أكاديمية
Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers.
| العنوان: | Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers. |
|---|---|
| المؤلفون: | Mishra M; Amity Institute of Biotechnology, Amity University, Noida 201301, India., Ahmed R; Department of Physiology, University of Gour Banga, Malda-732103, West Bengal, India., Das DK; Department of Chemistry and Nanoscience, GLA University, Mathura, 281406 Uttar Pradesh, India., Pramanik DD; Amity Institute of Biotechnology, Amity University, Noida 201301, India., Dash SK; Department of Physiology, University of Gour Banga, Malda-732103, West Bengal, India., Pramanik A; Amity Institute of Biotechnology, Amity University, Noida 201301, India.; School of Medicine, University of Leeds, Leeds LS53RL, United Kingdom. |
| المصدر: | ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2024 Aug 12; Vol. 10 (8), pp. 4740-4756. Date of Electronic Publication: 2024 Jul 01. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101654670 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-9878 (Electronic) Linking ISSN: 23739878 NLM ISO Abbreviation: ACS Biomater Sci Eng Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Washington, DC : American Chemical Society, [2015]- |
| مواضيع طبية MeSH: | Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Biomarkers, Tumor*/blood , Biomarkers, Tumor*/genetics , Early Detection of Cancer*/methods , Neoplasms*/diagnosis , Neoplasms*/genetics , Neoplasms*/blood, Humans ; Biosensing Techniques/methods |
| مستخلص: | Early detection of cancer is vital for increasing patient survivability chances. The three major techniques used to diagnose cancers are instrumental examination, tissue biopsy, and tumor biomarker detection. Circulating tumor DNA (ctDNA) has gained much attention in recent years due to advantages over traditional technology, such as high sensitivity, high specificity, and noninvasive nature. Through the mechanism of apoptosis, necrosis, and circulating exosome release in tumor cells, ctDNA can spread throughout the circulatory system and carry modifications such as methylations, mutations, gene rearrangements, and microsatellite instability. Traditional gene-detection technology struggles to achieve real-time, low-cost, and portable ctDNA measurement, whereas electrochemical biosensors offer low cost, high specificity alongside sensitivity, and portability for the detection of ctDNA. Therefore, this review focuses on describing the recent advancements in ctDNA biomarkers for various cancer types and biosensor developments for real-time, noninvasive, and rapid ctDNA detection. Further in the review, ctDNA sensors are also discussed in regards to their selections of probes for receptors based on the electrode surface recognition elements. |
| References: | Eur J Cancer. 2019 Jul;116:56-66. (PMID: 31173963) Dis Mon. 2013 Nov;59(11):368-402. (PMID: 24183261) Anal Chem. 2022 Feb 15;94(6):2779-2784. (PMID: 35107269) Br J Cancer. 2022 Aug;127(3):383-393. (PMID: 35264788) ACS Nano. 2022 Mar 22;16(3):4726-4733. (PMID: 35188755) Ann Oncol. 2018 May 1;29(5):1286-1291. (PMID: 29509837) Curr Mol Med. 2013 Mar;13(3):340-51. (PMID: 23331006) Klin Onkol. 2016 Fall;29(5):342-346. (PMID: 27739312) PLoS One. 2020 Mar 20;15(3):e0230622. (PMID: 32196518) Eur J Cancer. 2009 Jan;45(2):228-47. (PMID: 19097774) Sci Rep. 2018 Apr 23;8(1):6418. (PMID: 29686400) Clin Cancer Res. 2018 Jun 1;24(11):2505-2516. (PMID: 29490986) Cancer Discov. 2021 Apr;11(4):858-873. (PMID: 33811121) Oral Oncol. 2013 Dec;49(12):1097-102. (PMID: 24103389) Semin Hematol. 2016 Jul;53(3):139-47. (PMID: 27496304) World J Gastroenterol. 2014 Apr 28;20(16):4723-9. (PMID: 24782625) Blood. 2015 Jun 11;125(24):3679-87. (PMID: 25887775) Nat Rev Clin Oncol. 2022 Sep;19(9):600-612. (PMID: 35915225) Nat Biomed Eng. 2022 Mar;6(3):232-245. (PMID: 35102279) Int J Colorectal Dis. 2020 Aug;35(8):1463-1475. (PMID: 32572601) Medicine (Baltimore). 2015 Jun;94(25):e987. (PMID: 26107683) Sci Rep. 2020 Jul 28;10(1):12564. (PMID: 32724107) Science. 2018 Feb 23;359(6378):926-930. (PMID: 29348365) Semin Cancer Biol. 2021 Nov;76:232-246. (PMID: 34062264) Mol Cancer. 2022 Jul 14;21(1):144. (PMID: 35836256) BMC Cancer. 2020 Oct 16;20(1):1006. (PMID: 33066758) Noncoding RNA. 2020 Jun 30;6(3):. (PMID: 32629922) Biosens Bioelectron. 2015 May 15;67:443-9. (PMID: 25220802) Zhonghua Gan Zang Bing Za Zhi. 2014 Jan;22(1):2. (PMID: 24754083) Biosens Bioelectron. 2018 May 15;105:116-120. (PMID: 29367008) Front Oncol. 2018 Jun 04;8:193. (PMID: 29915720) Biosens Bioelectron. 2021 Jun 1;181:113147. (PMID: 33773219) Open Life Sci. 2023 May 19;18(1):20220615. (PMID: 37250841) Oral Oncol. 2020 May;104:104631. (PMID: 32169746) Br J Cancer. 2022 Feb;126(3):401-408. (PMID: 34373567) Nat Cancer. 2020 Mar;1(3):276-290. (PMID: 35122035) Nature. 2015 Feb 26;518(7540):495-501. (PMID: 25719666) Cancer Med. 2019 Jan;8(1):408-417. (PMID: 30575318) Science. 2022 Mar 18;375(6586):eaay9040. (PMID: 35298272) Nat Rev Genet. 2019 Feb;20(2):71-88. (PMID: 30410101) Biosensors (Basel). 2022 Aug 17;12(8):. (PMID: 36005048) Ann Surg Oncol. 2021 Jun;28(6):3145-3146. (PMID: 33393027) Ann Hematol. 2022 Nov;101(11):2393-2403. (PMID: 36074181) Lancet Haematol. 2015 Feb;2(2):e55-65. (PMID: 26687610) Cancer Lett. 1997 Jun 3;116(1):111-6. (PMID: 9177465) Cancers (Basel). 2022 Sep 14;14(18):. (PMID: 36139621) Talanta. 2020 Sep 1;217:121091. (PMID: 32498898) Clin Cancer Res. 2018 Oct 1;24(19):4650-4661. (PMID: 29950351) Nucleic Acids Res. 2018 Sep 6;46(15):e89. (PMID: 29897492) Clin Cancer Res. 2017 Sep 15;23(18):5416-5425. (PMID: 28576867) Oncotarget. 2016 Dec 20;7(51):85349-85364. (PMID: 27863403) Biosens Bioelectron. 2018 Dec 30;122:224-230. (PMID: 30265973) Biosens Bioelectron. 2020 Oct 28;173:112777. (PMID: 33189015) Cancer Res. 2014 Jun 1;74(11):2913-21. (PMID: 24840647) Biomark Insights. 2019 Feb 01;14:1177271919826545. (PMID: 30745794) Diagnostics (Basel). 2021 Nov 23;11(12):. (PMID: 34943407) JCO Oncol Pract. 2020 Sep;16(9):561-568. (PMID: 32421389) Cancer Prev Res (Phila). 2015 Nov;8(11):1017-26. (PMID: 26304463) Sci Rep. 2019 Aug 8;9(1):11542. (PMID: 31395942) BMC Cancer. 2021 Jan 11;21(1):49. (PMID: 33430810) Head Neck. 2021 Jun;43(6):1812-1822. (PMID: 33594807) Ann Oncol. 2018 Sep 1;29(9):1980-1986. (PMID: 30010779) Blood Cancer Discov. 2022 Jan;3(1):5-15. (PMID: 35015693) Int J Med Sci. 2014 Jan 07;11(2):164-71. (PMID: 24465162) J Hematol Oncol. 2022 Sep 12;15(1):131. (PMID: 36096847) Ann Oncol. 2015 Aug;26(8):1715-22. (PMID: 25851626) Nat Rev Dis Primers. 2020 Jul 23;6(1):61. (PMID: 32703953) J Gastrointest Oncol. 2012 Jun;3(2):105-19. (PMID: 22811878) Anal Chim Acta. 2020 Jul 18;1121:17-25. (PMID: 32493585) Oncotarget. 2016 Jul 26;7(30):48832-48841. (PMID: 27223063) Blood. 2018 May 31;131(22):2413-2425. (PMID: 29449275) Anal Chim Acta. 2020 Jul 18;1121:35-41. (PMID: 32493587) Clin Chem Lab Med. 2014 Jun;52(6):899-909. (PMID: 24406287) Clin Chem. 2013 Dec;59(12):1722-31. (PMID: 23938455) Blood. 2016 May 19;127(20):2375-90. (PMID: 26980727) J Cancer. 2016 Jan 12;7(4):364-6. (PMID: 26918050) Ann Oncol. 2018 Dec 1;29(12):2348-2355. (PMID: 30346475) Acta Oncol. 2020 Jul;59(7):845-850. (PMID: 32223478) Arch Pathol Lab Med. 2018 Feb;142(2):163-167. (PMID: 29106293) Annu Rev Med. 2020 Jan 27;71:117-136. (PMID: 31986082) World J Clin Cases. 2022 Aug 6;10(22):7686-7697. (PMID: 36158487) Br J Haematol. 2019 Jan;184(1):45-59. (PMID: 30407610) Clin Cancer Res. 2022 Feb 15;28(4):719-727. (PMID: 34857594) J Cell Biochem. 2019 Oct;120(10):17422-17437. (PMID: 31127647) Oncol Rep. 2017 Apr;37(4):2506-2512. (PMID: 28259999) Nanotheranostics. 2018 Jan 1;2(1):12-20. (PMID: 29291160) Trends Mol Med. 2012 Jul;18(7):405-16. (PMID: 22727782) Klin Onkol. 2014;27(6):406-23. (PMID: 25493580) Hepatol Int. 2013 Jul;7(3):893-900. (PMID: 26201927) J Clin Oncol. 2021 Aug 10;39(23):2605-2616. (PMID: 33909455) Mikrochim Acta. 2021 Dec 2;189(1):2. (PMID: 34855037) Lancet Oncol. 2015 May;16(5):541-9. (PMID: 25842160) Acta Cytol. 2019;63(6):489-496. (PMID: 30566947) Sci Transl Med. 2015 Jun 24;7(293):293ra104. (PMID: 26109104) J Exp Med. 1996 Oct 1;184(4):1495-505. (PMID: 8879220) Lancet Gastroenterol Hepatol. 2019 Dec;4(12):895-896. (PMID: 31648975) Eur J Cancer. 2021 Feb;144:368-381. (PMID: 33422803) Cancer Epidemiol. 2022 Feb;76:102080. (PMID: 34922050) N Biotechnol. 2020 Mar 25;55:19-29. (PMID: 31580920) Int J Cancer. 2017 May 15;140(10):2344-2350. (PMID: 28205231) Tumour Biol. 2024;46(s1):S283-S295. (PMID: 37270828) J Clin Invest. 2012 Oct;122(10):3439-47. (PMID: 23023715) Oncotarget. 2016 Nov 29;7(48):78985-78993. (PMID: 27738317) Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947. (PMID: 31648972) Cancer Cell. 2007 Mar;11(3):217-27. (PMID: 17349580) Ann Oncol. 2002;13 Suppl 1:44-51. (PMID: 12078902) Cancers (Basel). 2022 Jun 16;14(12):. (PMID: 35740633) Genetics. 2018 May;209(1):27-29. (PMID: 29716984) J Hepatol. 2017 Aug;67(2):293-301. (PMID: 28323123) Anal Chim Acta. 2020 Apr 22;1107:40-47. (PMID: 32200900) J Am Chem Soc. 2016 Aug 31;138(34):11009-16. (PMID: 27513828) Science. 2008 Sep 26;321(5897):1801-6. (PMID: 18772397) Curr Hematol Malig Rep. 2022 Dec;17(6):298-305. (PMID: 36214943) Semin Cell Dev Biol. 2020 Feb;98:63-70. (PMID: 31129171) Medicina (Kaunas). 2023 Sep 12;59(9):. (PMID: 37763765) Nat Commun. 2015 Jul 07;6:7686. (PMID: 26154128) Clin Cancer Res. 2017 Jan 1;23(1):116-123. (PMID: 27993964) Am J Physiol Cell Physiol. 2011 May;300(5):C1078-89. (PMID: 21270292) J Cancer. 2019 Aug 28;10(21):5041-5048. (PMID: 31602255) Analyst. 2016 Oct 17;141(21):5922-5943. (PMID: 27704092) Br J Cancer. 2021 Jan;124(2):345-358. (PMID: 32968207) Haematologica. 2004 Aug;89(8):965-72. (PMID: 15339680) Haematologica. 2016 Sep;101(9):1094-101. (PMID: 27479820) Am J Pathol. 2002 Nov;161(5):1861-7. (PMID: 12414532) Drug Discov Today. 2021 Jan;26(1):69-79. (PMID: 33137482) J Pers Med. 2022 Jan 13;12(1):. (PMID: 35055414) |
| فهرسة مساهمة: | Keywords: Cancer Biomarker; Cell free DNA; Circulating tumor DNA; DNA methylation; DNA probes; RNA probes |
| المشرفين على المادة: | 0 (Circulating Tumor DNA) 0 (Biomarkers, Tumor) |
| تواريخ الأحداث: | Date Created: 20240701 Date Completed: 20240812 Latest Revision: 20240818 |
| رمز التحديث: | 20240818 |
| مُعرف محوري في PubMed: | PMC11322919 |
| DOI: | 10.1021/acsbiomaterials.4c00606 |
| PMID: | 38950521 |
| قاعدة البيانات: | MEDLINE |
Find this issue from the American Chemical Society | تدمد: | 2373-9878 |
|---|---|
| DOI: | 10.1021/acsbiomaterials.4c00606 |